INDP icon

Indaptus Therapeutics
INDP

Overview Fund Activity

26 hedge funds and large institutions have $65.6M invested in Indaptus Therapeutics in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
11
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PM
1
Prosight Management
Texas
$4.95M
2
MIH
2
Meitav Investment House
Israel
$11.4M
3
DCM
3
DAFNA Capital Management
California
$2.5M
4
SAM
4
Sectoral Asset Management
Quebec, Canada
$3.92M
5
ACA
5
Avoro Capital Advisors
New York
$11.3M

Top Sellers

1
AFM
1
Anson Funds Management
Texas
$0
2
EMG
2
ETF Managers Group
New Jersey
$0
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$0
5
OAM
5
Oxford Asset Management
United Kingdom
$133K
Name Holding Trade Value Shares
Change 		Shares
Change %
Geode Capital Management
26
Geode Capital Management
Massachusetts
$55K +$55K +6 New
Bank of America
27
Bank of America
North Carolina
$1K -$1K – –
AFM
28
Anson Funds Management
Texas
– -$316K -22 Closed
EMG
29
ETF Managers Group
New Jersey
– -$175K -13 Closed
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
– -$173K -12 Closed
JPMorgan Chase & Co
31
JPMorgan Chase & Co
New York
– -$138K -10 Closed
ARTA
32
A.R.T. Advisors
New York
– -$85K -6 Closed
IA
33
IFP Advisors
Florida
– -$1K – –
1
2